Cargando…
What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131807/ https://www.ncbi.nlm.nih.gov/pubmed/35345066 http://dx.doi.org/10.4103/ijmr.ijmr_2573_21 |
_version_ | 1784713252366712832 |
---|---|
author | Sharma, Surendra Kumar Upadhyay, Vishwanath Mohan, Alladi |
author_facet | Sharma, Surendra Kumar Upadhyay, Vishwanath Mohan, Alladi |
author_sort | Sharma, Surendra Kumar |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9131807 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-91318072022-05-26 What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease? Sharma, Surendra Kumar Upadhyay, Vishwanath Mohan, Alladi Indian J Med Res Editorial Wolters Kluwer - Medknow 2021-09 /pmc/articles/PMC9131807/ /pubmed/35345066 http://dx.doi.org/10.4103/ijmr.ijmr_2573_21 Text en Copyright: © 2021 Indian Journal of Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Editorial Sharma, Surendra Kumar Upadhyay, Vishwanath Mohan, Alladi What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease? |
title | What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease? |
title_full | What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease? |
title_fullStr | What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease? |
title_full_unstemmed | What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease? |
title_short | What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease? |
title_sort | what is new in bts 2017 & ats/ers/escmid/idsa 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131807/ https://www.ncbi.nlm.nih.gov/pubmed/35345066 http://dx.doi.org/10.4103/ijmr.ijmr_2573_21 |
work_keys_str_mv | AT sharmasurendrakumar whatisnewinbts2017atsersescmididsa2020guidelinesontreatmentofnontuberculousmycobacterialpulmonarydisease AT upadhyayvishwanath whatisnewinbts2017atsersescmididsa2020guidelinesontreatmentofnontuberculousmycobacterialpulmonarydisease AT mohanalladi whatisnewinbts2017atsersescmididsa2020guidelinesontreatmentofnontuberculousmycobacterialpulmonarydisease |